Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Subscriptions

Clara cell secretory protein (CC16) and surfactant protein D (SPD) in sputum supernatant in severe refractory asthma (SRA)

Philip Emmanouil, Stelios Loukides, Kostantinos Kostikas, Anastasia Papaporfyriou, George Hillas, George Papatheodorou, Spyros Papiris, Manos Alchanatis, Petros Bakakos
European Respiratory Journal 2012 40: P302; DOI:
Philip Emmanouil
11st Department of Pulmonary Medicine, University of Athens, Sotiria Chest Hospital, Athens, Greece
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stelios Loukides
22nd Department of Pulmonary Medicine, University of Athens, Attikon University Hospital, Athens, Greece
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kostantinos Kostikas
22nd Department of Pulmonary Medicine, University of Athens, Attikon University Hospital, Athens, Greece
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anastasia Papaporfyriou
22nd Department of Pulmonary Medicine, University of Athens, Attikon University Hospital, Athens, Greece
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
George Hillas
11st Department of Pulmonary Medicine, University of Athens, Sotiria Chest Hospital, Athens, Greece
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
George Papatheodorou
11st Department of Pulmonary Medicine, University of Athens, Sotiria Chest Hospital, Athens, Greece
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Spyros Papiris
22nd Department of Pulmonary Medicine, University of Athens, Attikon University Hospital, Athens, Greece
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Manos Alchanatis
11st Department of Pulmonary Medicine, University of Athens, Sotiria Chest Hospital, Athens, Greece
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Petros Bakakos
11st Department of Pulmonary Medicine, University of Athens, Sotiria Chest Hospital, Athens, Greece
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading

Abstract

Background: Severe refractory asthma (SRA) is characterized by amplified inflammatory/remodeling process. CC16 is associated with Th2 modulation. SPD plays an important role in surfactant homeostasis & eosinophil chemotaxis.

Aim: Measurement of CC16 & SPD levels in sputum supernatants of SRA patients, comparison with mild to moderate asthma and controls and investigation of inflammatory/remodelling mediator or cell associations.

Methods: 31 optimally treated SRA patients, 33 mild to moderate asthmatics and 12 controls were studied. All underwent lung function tests, bronchial hyperresponsiveness and Exhaled Nitric Oxide (FeNO) assessment, sputum induction for differential cell count and CC16, SPD, Il-8, IL-13, TGF-β & ECP measurement in sputum supernatants.

Results: CC16 [median (interquartile range) ng/ml] was significantly elevated in SRA compared to mild-moderate asthma and controls [214 (59-900) vs 58 (38-95) vs 33 (21-53), p<0.001].

SPD [ng/ml] was significantly elevated in SRA compared to mild to moderate asthma and controls [28.5 (18-45) vs 6.1 (4-9) vs 4.8 (3.4-7), p<0.001]. No difference was observed between mild to moderate asthmatics and controls for either CC16 or SPD. Regression analysis did not reveal significant associations between CC16 or SPD and sputum differential count, inflammatory/remodeling mediators, FeNO or lung function tests. A significant but moderate positive association was observed between CC16 and SPD [r2=0.2].

Conclusions: SPD & CC16 levels are upregulated in SRA compared to mild to moderate asthmatics and controls, being consistent with the hypothesis that epithelium injury & repair play an important role in this phenotype.

  • Asthma - mechanism
  • Biomarkers
  • Inflammation
  • © 2012 ERS
Previous
Back to top
Vol 40 Issue Suppl 56 Table of Contents
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Clara cell secretory protein (CC16) and surfactant protein D (SPD) in sputum supernatant in severe refractory asthma (SRA)
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Clara cell secretory protein (CC16) and surfactant protein D (SPD) in sputum supernatant in severe refractory asthma (SRA)
Philip Emmanouil, Stelios Loukides, Kostantinos Kostikas, Anastasia Papaporfyriou, George Hillas, George Papatheodorou, Spyros Papiris, Manos Alchanatis, Petros Bakakos
European Respiratory Journal Sep 2012, 40 (Suppl 56) P302;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Clara cell secretory protein (CC16) and surfactant protein D (SPD) in sputum supernatant in severe refractory asthma (SRA)
Philip Emmanouil, Stelios Loukides, Kostantinos Kostikas, Anastasia Papaporfyriou, George Hillas, George Papatheodorou, Spyros Papiris, Manos Alchanatis, Petros Bakakos
European Respiratory Journal Sep 2012, 40 (Suppl 56) P302;
Reddit logo Technorati logo Twitter logo Connotea logo Facebook logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
  • Info & Metrics
  • PDF
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • Clinical differences between emphysematous and non-emphysematous COPD
  • Clinical and epidemiological assessment of the regional program of vaccination for pneumococcal infections
  • Risk for adverse outcomes in asthma: Assess to impress!
Show more 5.2 Monitoring Airway Disease

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2023 by the European Respiratory Society